How To Control Scalp And Elbow Psoriasis?

Brief Answer:
Topical steroids are mainstay of trratment in psoriasis

Detailed Answer:
Hello. Thank you for writing to us.

I have taken note of your query and I will try to guide you in the best possible way.

Psoriasis is a steroid responsive dermatosis and therefore topical potent steroids e.g clobetasol propionate 0.05%, betamethasone dipropionate 0.05%, halobetasol propionate 0.05% etc are mainstay of treatment.

Topical steroids may be combined with salicylic acid.

Ointment form is preferred for skin involvement and lotions are for scalp involvement.

In addition coal tar+salicylic acid based shampoo is also of benefit in scalp psoriasis.

Topical steroids are prescription drugs and therefore you need to talk to a doctor for the needful.

Regards

---

Brief Answer:
Topical steroids and vitamin D analogues suffice for limited involvement

Detailed Answer:
Hi.

I am sorry but I am not aware about particular TV adds for psoriasis medicines but you can ask me specifically about what all antipsoriatic medicines these adds are all about.

I am sure i can help clear your doubts.

You seem to have limited involvement of elbow and scalp and in my view topical potent steroids with or without salicylic acid; topical vitamin D analogues are good choices for limited body & scalp involvement with psoriasis.

Regards

---

Brief Answer:
BRM's not 1st line Rx for limited psorisis; Can have serious side effects

Detailed Answer:
Hi.

Humira is 'adalimumab' and stelara is 'ustekinumab'.

These are biologic response modifiers/ BRM's and are really effective molecules for widespread, recalcitrant plaque psoriasis.

Psoriasis is an immune mediated disease and these BRM's modify or alter the cascade or steps involved in the immune response leading to the generation of clinical lesions of psoriasis.

These BRM's can achieve lasting and faster remissions. However, they are not a cure for psoriasis and they need to be re-administered.

Adalimumab is a human monoclonal antibody that inhibits TNF-alpha, an important inflammatory mediator in psoriasis.
It is administered by subcutaneous injections, once every 2 weeks.

Ustekinumab is also a human monoclonal antibody.
It works by inhibiting the proteins (interleukins; IL-12 and IL-23) necessary to activate a cascade of inflammatory mediators responsible in the pathogenesis of psoriasis.
It is also to be injected.

Side effects of BRM's: They can cause re-activation of tuberculosis, hepatitis and opportunistic infections (bacterial, viral and fungal).
Adalimumab should be used with caution in old patients with a history of congestive heart failure.
These can affect the CNS therefore caution is also to be exercised in those who have CNS disorders like multiple sclerosis and those with a history or risk factors for skin cancers.

These BRM's are not 1st line treatment for limited plaque psoriasis.
They are reserved for widespread & extensive, recalcitrant plaque psoriasis which is not responding adequately to traditional antipsoriatic medications.

Regards

---

Brief Answer:
You are welcome

Detailed Answer:
Thank you for writing to us at healthcaremagic

Wish you good health
regards

---